Winstonepoint Pharmaceuticals Private Limited
About Winstonepoint Pharmaceuticals Private Limited
Data last updated:
Winstonepoint Pharmaceuticals Private Limited is a private limited company based in Pune, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 13 July 2017 and has been in existence for over 9 years.
The company is registered with the Registrar of Companies (ROC), Pune, under CIN U74999PN2017PTC171444. The company has 1 GST registration on record, which is no longer active.
The company has an authorised share capital of ₹3.5 Lakh and a paid-up capital of ₹3.5 Lakh. It is led by directors including Sharad Chagan Alhat and Chandrashekar Gulabrao Ingle.
Its last annual general meeting (AGM) was held on 30 October 2018, and its latest financial statements are for the year ended 31 March 2018. The registered office is at Flat No. 1203 Juliana Niyati Esplanade S. No. 265 2 Bawdhan Bk, Pune, Maharashtra, India – 411021.
The current compliance status is marked as active non-compliant by the Registrar of Companies.
Company details
Contact details
Winstonepoint Pharmaceuticals Private Limited's registered office is in Pune, Maharashtra. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressFlat No. 1203 Juliana Niyati Esplanade S. No. 265 2 Bawdhan Bk, Pune, Maharashtra, India – 411021
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Winstonepoint Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Winstonepoint Pharmaceuticals is hospital and medical care. In detail, this covers hospital activities.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| Q | Hospital and Medical Care | Q1 | Hospital activities |
Financials of Winstonepoint Pharmaceuticals Private Limited
FY 2018 filings availableFinancial Statement Summary
| Metrics | FY 2017-18 |
|---|---|
| Profit and Loss Statement | |
| Revenue from Operations | |
| Other Income | |
| Total Revenue | |
| Cost of Materials Consumed | |
| Employee Benefit Expense | |
| Finance Costs | |
| Depreciation and Amortisation | |
| Other Expenses | |
| Total Expenses | |
| EBITDA | |
| Profit Before Tax | |
| Tax Expense | |
| Net Profit (PAT) | |
| Balance Sheet | |
| Share Capital | |
| Reserves and Surplus | |
| Net Worth (Total Equity) | |
| Long-term Borrowings | |
| Short-term Borrowings | |
| Trade Payables | |
| Total Liabilities | |
| Fixed Assets | |
| Investments | |
| Inventories | |
| Trade Receivables | |
| Cash and Bank Balance | |
| Total Assets | |
Financial Ratios
| Metrics | FY 2017-18 |
|---|---|
| Profitability | |
| EBITDA Margin | |
| Net Profit Margin | |
| Return on Equity (ROE) | |
| Return on Capital Employed (ROCE) | |
| Return on Assets (ROA) | |
| Liquidity and Debt | |
| Current Ratio | |
| Quick Ratio | |
| Debt-to-Equity Ratio | |
| Interest Coverage Ratio | |
| Efficiency and Growth | |
| Asset Turnover | |
| Receivable Days | |
| Payable Days | |
| Inventory Days | |
| Revenue Growth | |
| Net Profit Growth | |
To see the full financial statements and ratios of Winstonepoint Pharmaceuticals Private Limited, buy the company report.
Board of directors of Winstonepoint Pharmaceuticals Private Limited
Winstonepoint Pharmaceuticals has 6 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sharad Chagan Alhat Also directs: Saialexin Pharmaceutical Private Limited | Director | 13 Jul 2017 | 9 Years 3 Months | Current |
| Chandrashekar Gulabrao Ingle Also directs: Prowings Health Solution Private Limited | Director | 13 Jul 2017 | 9 Years 3 Months | Current |
| Dattatraya Vishnu Shewale Also directs: Prowings Health Solution Private Limited | Additional Director | 25 Jul 2018 | 8 Years 3 Months | Current |
| Rajendra Thakchand Khandagale Also directs: Prowings Health Solution Private Limited | Director | 13 Jul 2017 | 9 Years 3 Months | Current |
| Balu Vishnu Hadawale | Additional Director | 25 Jul 2018 | 8 Years 3 Months | Current |
| Rahul Mahadev Gosavi Also directs: Prowings Health Solution Private Limited | Additional Director | 25 Jul 2018 | 8 Years 3 Months | Current |
Auditor
Winstonepoint Pharmaceuticals Private Limited is audited by C A MAHORE & CO for the financial year 2018.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| C A MAHORE & CO | FY 2018 | 141986W |
Shareholding
The shareholding of Winstonepoint Pharmaceuticals Private Limited is on record for FY 2018, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2018 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Public | |
| Others |
To see the full shareholding pattern of Winstonepoint Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Winstonepoint Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Winstonepoint Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Winstonepoint Pharmaceuticals has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.
To see the full GST registrations and return filing status of Winstonepoint Pharmaceuticals Private Limited, buy the company report.
Recent activity
Winstonepoint Pharmaceuticals Private Limited has 8 board changes on record since 2017: 6 appointments and 2 cessations. The latest: Balu Vishnu Hadawale was appointed as Additional Director on 25 Jul 2018.
Frequently asked questions
Winstonepoint Pharmaceuticals is an active private limited company based in Pune, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 13 July 2017 (9+ years old) and is registered under CIN U74999PN2017PTC171444.
Winstonepoint Pharmaceuticals has 6 current directors:
- Sharad Chagan Alhat - Director
- Chandrashekar Gulabrao Ingle - Director
- Dattatraya Vishnu Shewale - Additional Director
- Rajendra Thakchand Khandagale - Director
- Balu Vishnu Hadawale - Additional Director
- Rahul Mahadev Gosavi - Additional Director
The latest financial statements of Winstonepoint Pharmaceuticals on record with the MCA are for the year ended 31 March 2018. Its last annual general meeting was held on 30 October 2018. Year-wise statements from FY 2018 are in the company report.
No. Winstonepoint Pharmaceuticals has 1 GST registration on record and it is cancelled or inactive.
The CIN (Corporate Identification Number) of Winstonepoint Pharmaceuticals is U74999PN2017PTC171444. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Winstonepoint Pharmaceuticals was incorporated on 13 July 2017, making it 9+ years old. It is registered with the Registrar of Companies, Pune.
Balu Vishnu Hadawale was appointed as Additional Director on 25 Jul 2018. Dattatraya Vishnu Shewale was appointed as Additional Director on 25 Jul 2018. Rahul Mahadev Gosavi was appointed as Additional Director on 25 Jul 2018. Winstonepoint Pharmaceuticals has 8 board changes on record in total.
The registered office of Winstonepoint Pharmaceuticals is at Flat No. 1203 Juliana Niyati Esplanade S. No. 265 2 Bawdhan Bk, Pune, Maharashtra, India – 411021.
Winstonepoint Pharmaceuticals operates in the pharma industry, in the drug formulation and development segment.
The compliance status of Winstonepoint Pharmaceuticals is active non-compliant as of 17 September 2026. The company is actively filing with the Registrar of Companies.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
